Hikma Pharmaceutic (OTC:HKMPF) was downgraded by analysts at HSBC Holdings plc from a “hold” rating to a “reduce” rating in a research report issued on Friday.

Shares of Hikma Pharmaceutic (OTC:HKMPF) opened at 26.50 on Friday. Hikma Pharmaceutic has a 12-month low of $20.43 and a 12-month high of $35.25. The company has a 50 day moving average price of $25.26 and a 200 day moving average price of $24.41. The firm has a market cap of $5.99 billion and a PE ratio of 32.40.

Your IP Address:

Receive News & Stock Ratings for Hikma Pharmaceutic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceutic and related stocks with our FREE daily email newsletter.